LRPAP1 and Alzheimer disease: Strikingly, through studies on hippocampal samples of patients with AD, we observed that miR-603 exhibits a relatively higher expression and there is a loss of a negative correlation between miR-603 and LRPAP1/RND1 mRNA levels in the hippocampi of patients with AD.